Explorer les evidences

11,8 %11.8% of the 400 respondents tested positive for HIV.

NigeriaVIH/sidapublié 2023Journal of preventive medicine and hygienePubMeddocument de 9 observations

OSSN frequently showed an association with HIV infection at a tertiary referral centre in North West Nigeria.

Nigeriaocular surface squamous neoplasia (OSSN) · VIH/sidapublié 2022International ophthalmologyPubMeddocument de 5 observations

53 %In Nigeria, 53% of people living with HIV utilize HIV care and services.

NigeriaVIH/sidapublié 2020BMC health services researchPubMeddocument de 2 observations

5 %The prevalence of prolonged PR interval was 5% in HIV-positive children.

NigeriaVIH/sidapublié 2020The Nigerian postgraduate medical journalPubMeddocument de 9 observations

326 casesOf 3229 study participants, 326 were HIV infected as confirmed by Western Blot or RNA.

NigeriaVIH/sidaobservé 2009-12publié 2016PloS onePubMeddocument de 14 observations

67,9 %Of the 2,739 PLHIV 15 years and above identified in NAIIS, 1,342 (67.9%) were linked to care.

NigeriaVIH/sidaobservé 2018publié 2021PloS onePubMeddocument de 13 observations

69,5 %Among HIV-infected women attending a tertiary health facility in Kano, Nigeria, 69.5% were aware of their transmission risk during pregnancy.

NigeriaVIH/sidapublié 2019International journal of health policy and managementPubMeddocument de 10 observations

19 %Among adults aged 25–49 years, 19% had tested for HIV in the last 12 months preceding the 2016/2017 Multiple Indicator Cluster Survey in Nigeria.

NigeriaVIH/sidaobservé 2016/2017publié 2020AIDS carePubMeddocument de 5 observations

34,5 %The prevalence of abnormal ECG findings in HIV-positive children was 34.5%.

NigeriaVIH/sidapublié 2020The Nigerian postgraduate medical journalPubMeddocument de 9 observations

4,8 %HIV seronegative women uninfected with HSV-2 had a cervical lesion prevalence of 4.8%.

NigeriaCervical Lesions · Herpes Simplex Virus Type-2 · VIH/sidapublié 2022Current HIV researchPubMeddocument de 4 observations

10,4 %La fréquence de la neuropathie chez les personnes vivant avec le VIH au Nigeria était de 10,4 % en 2009.

NigeriaVIH/sidaobservé 2009HAL · Unilimdocument de 747 observations

11,4 %At first viral load for 402,668 patients during 2016–21, virological non-suppression occurred in 46,051 (11.4%) individuals.

NigeriaVIH/sidaobservé 2016–21publié 2022The Lancet. Global healthPubMeddocument de 5 observations

24,9 %Of the 8,329 eligible women in the 2018 Nigerian National Nutrition and Health Survey, 1,493 (24.9%) missed HIV pre-test counselling.

NigeriaVIH/sidaobservé 2018publié 2022African journal of reproductive healthPubMeddocument de 5 observations

8,48 daysThe mean duration of hospitalization for HIV/AIDS admissions was 8.48 ± 7.08 days.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 11 observations

8,82 µmol/lThe mean plasma glutathione level was 8.82 ± 2.39 µmol/l in HIV infected children.

NigeriaVIH/sidapublié 2021West African journal of medicinePubMeddocument de 4 observations

78,5 %78.5% of the participants experienced psychological challenges in accessing care during the COVID-19-induced lockdown.

NigeriaVIH/sidapublié 2022Nigerian journal of clinical practicePubMeddocument de 9 observations

3,66 hazard_ratioPatients with advanced disease (Stage IV) had a significantly higher risk of being lost to follow-up (hazard ratio 3.66).

NigeriaVIH/sidapublié 2022Journal of the International Association of Providers of AIDS CarePubMeddocument de 4 observations

87,5 %The self-reported ART adherence level was 87.5% in the south-west of Nigeria.

NigeriaVIH/sidapublié 2022African journal of AIDS research : AJARPubMeddocument de 4 observations

1 000 NGNThe median maximum amount people living with HIV (PLHIV) on antiretroviral therapy (ART) were willing to pay for clinical consultation was NGN1,000 (USD $2.78), with an interquartile range of NGN500–NGN2,000.

NigeriaVIH/sidaobservé July and August 2019publié 2023PloS onePubMeddocument de 9 observations

Baseline LSM and median LSM decline were significantly higher in HIV/HBV- versus HIV-infected patients.

NigeriaHIV/HBV · VIH/sidapublié 2019The Journal of antimicrobial chemotherapyPubMeddocument de 8 observations

64,1 %The seroprevalence of cytomegalovirus (CMV) IgM antibodies among HIV-positive individuals attending the Ahmadu Bello University Teaching Hospital in Nigeria was 64.1%.

Nigeriacytomegalovirus (CMV) · VIH/sidapublié 2025Journal of infection in developing countriesPubMeddocument de 2 observations

3 796 sexual_contactsA total of 3,796 sexual contacts were elicited.

NigeriaVIH/sidaobservé Between March 2021 and April 2022publié 2024Global health, science and practicePubMeddocument de 8 observations

13 000 casesHIV incidence in Akwa Ibom state, Nigeria, translated to 13,000 new cases of HIV infections annually in 2017.

NigeriaVIH/sidaobservé 2017publié 2021Journal of the International AIDS SocietyPubMeddocument de 9 observations

45,9 %45.9% of HIV/AIDS admissions improved and were discharged home.

NigeriaVIH/sidapublié 2023West African journal of medicinePubMeddocument de 11 observations

12,34 aORClients receiving treatment at tertiary level facilities had an adjusted odds ratio of 12.34 for interruption of antiretroviral therapy.

NigeriaVIH/sidapublié 2021BMC public healthPubMeddocument de 12 observations